NCT07060157View on ClinicalTrials.gov

Comparative Efficacy of Resveratrol 1 % Gel and Trichloroacetic Acid 20% in Treatment of Melasma: A Split-face Study

NANot yet recruitingINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

July 22, 2025

Primary Completion Date

August 8, 2026

Study Completion Date

June 8, 2027

Conditions
Melasma
Interventions
DRUG

resveratrol 1 % gel

left side of face the patient will be given resveratrol 1 % gel once daily at night (Home use ).

DRUG

TCA20%

left side of face the patient will be given resveratrol 1 % gel once daily at night (homThee use ).

Trial Locations (1)

Unknown

Assuit, Asyut

All Listed Sponsors
lead

Assiut University

OTHER